Remove Article Remove Chronic Condition Remove Finance Remove Patient-Centered
article thumbnail

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law

Today we offer the article below on one of those pieces: an HHS report released to the public last Thursday outlining the Biden Administration’s strategies on drug pricing and payment reform. Controlling Medicare Part D Patient Out-of-Pocket Costs and Total Drug Costs. Part D currently has no such cap.